Scarica l'app Stockscreener
32.74
2.34%
0.75
Dopo l'orario di chiusura:
32.74
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Stoke Therapeutics Inc Borsa (STOK) Ultime notizie
Growth Value: What is the earnings history of Stoke Therapeutics Inc2026 Major Catalysts & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Insider Sell Alert: Barry Ticho Sells Shares of Stoke Therapeuti - GuruFocus
Stoke Therapeutics (STOK) CMO sells 1,838 shares in planned open-market trade - Stock Titan
(STOK) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Stoke Therapeutics (STOK) Price Target Increased by 16.51% to 28.79 - msn.com
Insider sells shares under 10b5-1 — STOK (NASDAQ: STOK) discloses trades - Stock Titan
Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
STOK Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Stoke Therapeutics (STOK) price target increased by 12.11% to 43.96 - msn.com
Stoke Therapeutics Hits Day High with 7.98% Surge in Strong Intraday Performance - Markets Mojo
Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares - AOL.com
Stoke Therapeutics, Inc. Files 8-K Announcing Change in Certifying Accountant – March 2026 - minichart.com.sg
Stoke Therapeutics (NASDAQ: STOK) replaces KPMG with EY as auditor - stocktitan.net
Vanguard reports zero Stoke Therapeutics holdings (STOK) - stocktitan.net
Big Money Moves: What hedge funds are buying Stoke Therapeutics Inc2026 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Stoke Therapeutics (NASDAQ:STOK) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Whale Trades: What is the earnings history of Stoke Therapeutics IncAnalyst Upgrade & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Assenagon Asset Management S.A. Boosts Position in Stoke Therapeutics, Inc. $STOK - MarketBeat
Gains Recap: How does Stoke Therapeutics Inc score in quality rankings2026 Historical Comparison & Expert Curated Trade Setups - baoquankhu1.vn
Allan Jonathan, Stoke Therapeutics general counsel, sells $313k in STOK stock - Investing.com Canada
Stoke Therapeutics Insider Sold Shares Worth $313,038, According to a Recent SEC Filing - MarketScreener
Stoke Therapeutics (STOK) counsel sells 9,293 shares under 10b5-1 plan - Stock Titan
Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally - Yahoo Finance
(STOK) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
FY2030 Earnings Estimate for STOK Issued By HC Wainwright - MarketBeat
Stoke Therapeutics Hits Day Low at $33.50 Amid Price Pressure - Markets Mojo
Stoke earnings loom as analysts bet big on Dravet therapy potential By Investing.com - Investing.com Australia
Stoke earnings loom as analysts bet big on Dravet therapy potential - Investing.com
Stoke Therapeutics (NASDAQ:STOK) Stock Rating Lowered by Wall Street Zen - MarketBeat
Form 144 STOKE THERAPEUTICS INC For: 20 March By Investing.com - Investing.com Canada
Form 144 STOKE THERAPEUTICS INC For: 20 March - Investing.com
Canaccord Genuity Group Forecasts Strong Price Appreciation for Stoke Therapeutics (NASDAQ:STOK) Stock - MarketBeat
Jonathan Allan plans sale of 9,293 RSUs at STOK (NASDAQ: STOK) - Stock Titan
Stoke Therapeutics stock price target raised to $60 by Canaccord on higher revenue assumptions - Investing.com Australia
Stoke Therapeutics Insider Sold Shares Worth $456,835, According to a Recent SEC Filing - marketscreener.com
Stoke Therapeutics Insider Sold Shares Worth $285,901, According to a Recent SEC Filing - marketscreener.com
Leggett, Stoke Therapeutics CFO, sells $147k in STOK stock By Investing.com - Investing.com Australia
Stoke Therapeutics’ chief medical officer Ticho sells shares worth $413k - Investing.com India
Allan, Jonathan, Stoke Therapeutics general counsel, sells $285k in STOK - Investing.com India
Stoke Therapeutics (NASDAQ:STOK) Insider Sells $60,517.54 in Stock - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Insider Sells $58,790.81 in Stock - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Insider Sells $209,539.24 in Stock - MarketBeat
Insider Selling: Stoke Therapeutics (NASDAQ:STOK) CFO Sells 2,382 Shares of Stock - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) General Counsel Sells $145,041.52 in Stock - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) CFO Sells $72,489.96 in Stock - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) General Counsel Jonathan Allan Sells 4,267 Shares - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Insider Barry Ticho Sells 6,164 Shares - MarketBeat
Allan, Jonathan, Stoke Therapeutics general counsel, sells $285k in STOK By Investing.com - Investing.com South Africa
Leggett, Stoke Therapeutics CFO, sells $147k in STOK stock - Investing.com
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):